MA28038A1 - Thienopyrazoles - Google Patents
ThienopyrazolesInfo
- Publication number
- MA28038A1 MA28038A1 MA28871A MA28871A MA28038A1 MA 28038 A1 MA28038 A1 MA 28038A1 MA 28871 A MA28871 A MA 28871A MA 28871 A MA28871 A MA 28871A MA 28038 A1 MA28038 A1 MA 28038A1
- Authority
- MA
- Morocco
- Prior art keywords
- thienopyrazoles
- modulable
- itk
- inhibition
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Les thiénopyrazoles, leur préparation, les compositions pharmaceutiques comprenant ces composés, et leurs utilisations pharmaceutiques dans le traitement d'états pathologiques modulables par l'inhibition des protéines kinases, en particulier de la tyrosine kinase inductible par l'interleukine-2 (ITK).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50115903P | 2003-09-08 | 2003-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28038A1 true MA28038A1 (fr) | 2006-07-03 |
Family
ID=34312256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28871A MA28038A1 (fr) | 2003-09-08 | 2006-03-13 | Thienopyrazoles |
Country Status (30)
Country | Link |
---|---|
US (2) | US7518000B2 (fr) |
JP (1) | JP4879739B2 (fr) |
KR (1) | KR20060069490A (fr) |
CN (1) | CN100398545C (fr) |
AT (1) | ATE468341T1 (fr) |
AU (1) | AU2004272507B2 (fr) |
BR (1) | BRPI0414215A (fr) |
CA (1) | CA2538032C (fr) |
CR (1) | CR8255A (fr) |
DE (1) | DE602004027288D1 (fr) |
DK (1) | DK1682553T3 (fr) |
EC (1) | ECSP066411A (fr) |
ES (1) | ES2345257T3 (fr) |
HK (1) | HK1095587A1 (fr) |
HR (1) | HRP20100398T1 (fr) |
IL (1) | IL173916A (fr) |
MA (1) | MA28038A1 (fr) |
ME (1) | MEP20908A (fr) |
MX (1) | MXPA06001827A (fr) |
MY (1) | MY144339A (fr) |
NO (1) | NO20061626L (fr) |
NZ (1) | NZ545421A (fr) |
OA (1) | OA13252A (fr) |
PT (1) | PT1682553E (fr) |
RS (2) | RS51846B (fr) |
RU (1) | RU2358978C2 (fr) |
TN (1) | TNSN06058A1 (fr) |
TW (1) | TWI352705B (fr) |
WO (1) | WO2005026175A1 (fr) |
ZA (1) | ZA200601947B (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006101454A1 (fr) * | 2005-03-21 | 2006-09-28 | S*Bio Pte Ltd | Derives du benzothiophene: preparation et applications pharmaceutiques |
CA2634061A1 (fr) * | 2005-12-20 | 2007-07-05 | Boehringer Ingelheim International Gmbh | Inhibiteurs de kinases tec |
EP2151434A1 (fr) | 2008-08-05 | 2010-02-10 | Institut Pasteur | Alkoxypyrazoles et leur procédé de préparation |
EP2151433A1 (fr) | 2008-08-05 | 2010-02-10 | Institut Pasteur | Alkoxypyrazoles et leur procédé de préparation |
US8299070B2 (en) * | 2009-11-25 | 2012-10-30 | Japan Tobacco Inc. | Indole compounds and pharmaceutical use thereof |
US20130158066A1 (en) * | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 4-azaindole inhibitors of crac |
WO2013153539A1 (fr) | 2012-04-13 | 2013-10-17 | Glenmark Pharmaceuticals S.A. | Composés tricycliques à titre d'inhibiteurs de kinases tec |
CN103467481B (zh) * | 2012-06-07 | 2016-08-31 | 上海汇伦生命科技有限公司 | 二氢吡啶类化合物、其组合物、制备方法和用途 |
UY34893A (es) | 2012-07-10 | 2014-02-28 | Takeda Pharmaceutical | Derivados de azaindol |
WO2014041518A1 (fr) * | 2012-09-14 | 2014-03-20 | Glenmark Pharmaceuticals S.A. | Composés thiénopyrrole comme inhibiteurs de l'itk |
CN103720694A (zh) * | 2012-10-11 | 2014-04-16 | 韩冰 | 一类治疗脑性瘫痪的化合物及其用途 |
CN103772391A (zh) * | 2012-10-23 | 2014-05-07 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
KR101571590B1 (ko) * | 2012-11-21 | 2015-11-25 | 주식회사 두산 | 유기 화합물 및 이를 이용하는 유기 전계 발광 소자 |
US9795604B2 (en) | 2013-10-25 | 2017-10-24 | Pharmacyclics Llc | Methods of treating and preventing graft versus host disease |
AR099052A1 (es) | 2014-01-09 | 2016-06-29 | Takeda Pharmaceuticals Co | Derivados de azaindol |
WO2016010108A1 (fr) * | 2014-07-18 | 2016-01-21 | 塩野義製薬株式会社 | Dérivés hétérocycliques contenant de l'azote et compositions médicinales le contenant |
WO2017040617A1 (fr) | 2015-08-31 | 2017-03-09 | Pharmacyclics Llc | Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple |
CN110139669A (zh) | 2016-11-03 | 2019-08-16 | 朱诺治疗学股份有限公司 | T细胞疗法和btk抑制剂的组合疗法 |
CA3098497A1 (fr) | 2018-05-03 | 2019-11-07 | Juno Therapeutics, Inc. | Polytherapie d'une therapie par lymphocytes t a recepteur antigenique chimerique (car) et d'un inhibiteur de btk |
WO2023139248A1 (fr) * | 2022-01-21 | 2023-07-27 | Ecole Polytechnique Federale De Lausanne (Epfl) | Inhibiteurs de thioestérases de protéine acyle contre des infections microbiennes |
WO2023220655A1 (fr) | 2022-05-11 | 2023-11-16 | Celgene Corporation | Méthodes pour surmonter la résistance aux médicaments par ré-sensibilisation de cellules cancéreuses à un traitement avec une thérapie antérieure par l'intermédiaire d'un traitement avec une thérapie par lymphocytes t |
WO2024123175A1 (fr) | 2022-12-06 | 2024-06-13 | Erasmus University Medical Center Rotterdam | Compositions pour le traitement de cancers résistants à la thérapie par blocage de point de contrôle immunitaire |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462036B1 (en) * | 1998-11-06 | 2002-10-08 | Basf Aktiengesellschaft | Tricyclic pyrazole derivatives |
US6297238B1 (en) * | 1999-04-06 | 2001-10-02 | Basf Aktiengesellschaft | Therapeutic agents |
NZ516348A (en) * | 1999-06-23 | 2003-06-30 | Aventis Pharma Gmbh | Substituted benzimidazole |
YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
WO2003024969A1 (fr) * | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Inhibiteurs des tyrosine kinases |
IL161576A0 (en) * | 2001-10-26 | 2004-09-27 | Aventis Pharma Inc | Benzimidazoles and analogues and their use as protein kinases inhibitors |
FR2831536A1 (fr) * | 2001-10-26 | 2003-05-02 | Aventis Pharma Sa | Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr |
-
2004
- 2004-07-23 TW TW093122172A patent/TWI352705B/zh active
- 2004-07-23 ME MEP-209/08A patent/MEP20908A/xx unknown
- 2004-07-23 DE DE602004027288T patent/DE602004027288D1/de not_active Expired - Lifetime
- 2004-07-23 JP JP2006525328A patent/JP4879739B2/ja not_active Expired - Fee Related
- 2004-07-23 AU AU2004272507A patent/AU2004272507B2/en not_active Ceased
- 2004-07-23 MY MYPI20042959A patent/MY144339A/en unknown
- 2004-07-23 DK DK04779049.8T patent/DK1682553T3/da active
- 2004-07-23 RS RS20060162A patent/RS51846B/en unknown
- 2004-07-23 WO PCT/US2004/023814 patent/WO2005026175A1/fr active Application Filing
- 2004-07-23 RS YUP-2006/0162A patent/RS20060162A/sr unknown
- 2004-07-23 RU RU2006111470/04A patent/RU2358978C2/ru not_active IP Right Cessation
- 2004-07-23 ES ES04779049T patent/ES2345257T3/es not_active Expired - Lifetime
- 2004-07-23 CA CA2538032A patent/CA2538032C/fr not_active Expired - Fee Related
- 2004-07-23 MX MXPA06001827A patent/MXPA06001827A/es active IP Right Grant
- 2004-07-23 OA OA1200600080A patent/OA13252A/en unknown
- 2004-07-23 KR KR1020067004795A patent/KR20060069490A/ko active IP Right Grant
- 2004-07-23 CN CNB2004800257424A patent/CN100398545C/zh not_active Expired - Fee Related
- 2004-07-23 BR BRPI0414215-2A patent/BRPI0414215A/pt not_active IP Right Cessation
- 2004-07-23 AT AT04779049T patent/ATE468341T1/de active
- 2004-07-23 NZ NZ545421A patent/NZ545421A/en not_active IP Right Cessation
- 2004-07-23 PT PT04779049T patent/PT1682553E/pt unknown
-
2006
- 2006-02-15 TN TNP2006000058A patent/TNSN06058A1/en unknown
- 2006-02-23 IL IL173916A patent/IL173916A/en not_active IP Right Cessation
- 2006-02-23 CR CR8255A patent/CR8255A/es not_active Application Discontinuation
- 2006-03-06 US US11/368,566 patent/US7518000B2/en not_active Expired - Fee Related
- 2006-03-06 EC EC2006006411A patent/ECSP066411A/es unknown
- 2006-03-07 ZA ZA200601947A patent/ZA200601947B/en unknown
- 2006-03-13 MA MA28871A patent/MA28038A1/fr unknown
- 2006-04-10 NO NO20061626A patent/NO20061626L/no not_active Application Discontinuation
-
2007
- 2007-01-17 HK HK07100592A patent/HK1095587A1/xx not_active IP Right Cessation
-
2009
- 2009-03-26 US US12/411,818 patent/US7928231B2/en not_active Expired - Fee Related
-
2010
- 2010-07-20 HR HR20100398T patent/HRP20100398T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28038A1 (fr) | Thienopyrazoles | |
BR9914360A (pt) | N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5 | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
SE0001899D0 (sv) | New compounds | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
MA29692B1 (fr) | Derives de la xanthine en tant qu'agonistes selectifs du hm74a | |
DE60104206D1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
HRP20060251A2 (en) | Substituted oxasolidinones and their use | |
EA200100872A1 (ru) | Композиция валдекоксиба | |
MA26709A1 (fr) | Compositions pharmaceutiques de celecoxib, leurs procedes de preparation et methodes de traitement les utilisant | |
BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
YU49202A (sh) | Benzazolski derivati i njihova upotreba kao modulatora jnk | |
BR0008687A (pt) | Métodos para o tratamento de, e para prevenir ou controlar, distúrbios gastrointestinais, disfunção da motilidade gastrointestinal, emese, e doença de refluxo gastro-esofageano em um paciente, e, composição farmacêutica | |
MA29377B1 (fr) | Derives de la pyrimidine pour traitement de troubles a caractere hyperproliferatif | |
MA27093A1 (fr) | Derives de sulfonamides, leur preparation et leur application comme medicaments. | |
ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
MA29213B1 (fr) | Quinolones a substitution macrolones - amino | |
MA29723B1 (fr) | Composes | |
MA29561B1 (fr) | DERIVES DE PYRIDO[2,3-d] PYRIMIDINE, LEUR PREPARATION, LEUR APPLICATION EN THERAPEUTIQUE | |
DE60141636D1 (de) | Phospholipidderivate von valproinsäure und ihre kombinationen | |
ATE312815T1 (de) | Neue verbindungen | |
WO2003017939A3 (fr) | Composes de piperazinone utilises comme agents antitumoraux et anticancereux et procedes de traitement | |
WO2001091796A8 (fr) | Methodes, composes et compositions permettant de traiter la goutte | |
DZ3459A1 (fr) | Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent. |